Replies to post #23020 on Amarantus Bioscience Holdings Inc (AMBS)

[golong22]

This pump fest is really overblown. Time to sell this pig down.

[TradeSmart.ai]

$10 in two years

[barbershop]

Looking forward to BioMedForum Jan 8th! San Francisco! AMBS to present.

[cjstocksup]

Buy the fear and panic!!! That is how I get rich!!! AMBS

[MagicCap]

I agree great point!

We will just keep responding to your bullish comments to show people your true colors

[MagicCap]

Solantey is right going to $1.00 or more.

FYI: We will just keep responding to your bullish comments to show people your true colors

"Big pharma" development partnership(s) or buyout in 2013.

$1.00 or more.

Major drug companies have billions of dollars to spend on acquisitions or partnerships.

AMBS is the most undervalued bio-tech in the market.

.20-.25 by 12/31/2012.

The co-founder of Amgen is 100% correct when he stated that the company's MANF technology would be worth billions and be a blockbuster drug.

[cjstocksup]

Nice post! I agree AMBS $1.00 soon

. "Big pharma" development partnership(s) or buyout in 2013.

$1.00 or more.

Major drug companies have billions of dollars to spend on acquisitions or partnerships.

AMBS is the most undervalued bio-tech in the market.

.20-.25 by 12/31/2012.

The co-founder of Amgen is 100% correct when he stated that the company's MANF technology would be worth billions and be a blockbuster drug.

[familyof5]

WOW!!!Solantey ~ "AMBS $1.00 or more"....REALLY!!!



"AMBS is the most undervalued bio-tech in the market.

.20-.25 by 12/31/2012." Solantey




Solantey Wednesday, December 19, 2012 8:35:16 AM
Re: None



"Big pharma" development partnership(s) or buyout in 2013.

$1.00 or more.

Major drug companies have billions of dollars to spend on acquisitions or partnerships.

AMBS is the most undervalued bio-tech in the market.

.20-.25 by 12/31/2012.

The co-founder of Amgen is 100% correct when he stated that the company's MANF technology would be worth billions and be a blockbuster drug.


http://investorshub.advfn.com/boards/read_msg.aspx?message_id=82611213





"I have been driven many times upon my knees by the overwhelming conviction that I had nowhere else to go."
Abraham Lincoln

"Jesus.....wise men still seek him"

[familyof5]

Solantey your AMBS $1.00 PPS prediction is low considering...

CEO BLOG (1/14/2013) Onwards and Upwards: Building Value From a Solid Foundation

SOURCE: http://www.thechairmansblog.com/gerald-commissiong/2013-01/onwards-and-upwards-building-value-from-a-solid-foundation.html



"Big pharma" development partnership(s) or buyout in 2013.

$1.00 or more." Solantey





Solantey Wednesday, December 19, 2012 8:35:16 AM
Re: None



"Big pharma" development partnership(s) or buyout in 2013.

$1.00 or more.

Major drug companies have billions of dollars to spend on acquisitions or partnerships.

AMBS is the most undervalued bio-tech in the market.

.20-.25 by 12/31/2012.

The co-founder of Amgen is 100% correct when he stated that the company's MANF technology would be worth billions and be a blockbuster drug.


http://investorshub.advfn.com/boards/read_msg.aspx?message_id=82611213





"I have been driven many times upon my knees by the overwhelming conviction that I had nowhere else to go."
Abraham Lincoln

"Jesus.....wise men still seek him"

[familyof5]

Solantey your AMBS $1.00 PPS prediction is low considering...

CEO BLOG (1/14/2013) Onwards and Upwards: Building Value From a Solid Foundation

SOURCE: http://www.thechairmansblog.com/gerald-commissiong/2013-01/onwards-and-upwards-building-value-from-a-solid-foundation.html



"Big pharma" development partnership(s) or buyout in 2013.

$1.00 or more." Solantey





Solantey Wednesday, December 19, 2012 8:35:16 AM
Re: None



"Big pharma" development partnership(s) or buyout in 2013.

$1.00 or more.

Major drug companies have billions of dollars to spend on acquisitions or partnerships.

AMBS is the most undervalued bio-tech in the market.

.20-.25 by 12/31/2012.

The co-founder of Amgen is 100% correct when he stated that the company's MANF technology would be worth billions and be a blockbuster drug.


http://investorshub.advfn.com/boards/read_msg.aspx?message_id=82611213





"I have been driven many times upon my knees by the overwhelming conviction that I had nowhere else to go."
Abraham Lincoln

"Jesus.....wise men still seek him"

[familyof5]

Solantey your AMBS $1.00 PPS prediction is low considering...


CEO BLOG (1/14/2013) Onwards and Upwards: Building Value From a Solid Foundation

SOURCE: http://www.thechairmansblog.com/gerald-commissiong/2013-01/onwards-and-upwards-building-value-from-a-solid-foundation.html



"Big pharma" development partnership(s) or buyout in 2013. $1.00 or more.AMBS is the most undervalued bio-tech in the market." Solantey





Solantey Wednesday, December 19, 2012 8:35:16 AM
Re: None


"Big pharma" development partnership(s) or buyout in 2013.

$1.00 or more.

Major drug companies have billions of dollars to spend on acquisitions or partnerships.

AMBS is the most undervalued bio-tech in the market.

.20-.25 by 12/31/2012.

The co-founder of Amgen is 100% correct when he stated that the company's MANF technology would be worth billions and be a blockbuster drug.


http://investorshub.advfn.com/boards/read_msg.aspx?message_id=82611213





"I have been driven many times upon my knees by the overwhelming conviction that I had nowhere else to go."
Abraham Lincoln

"Jesus.....wise men still seek him"

[familyof5]

"AMBS is the most undervalued bio-tech in the market"



"AMBS is the most undervalued bio-tech in the market" Solantey



I agree Solantey AMBS is the most undervalued bio-tech in the market IMHO :-) :-) :-) :-) :-)


Solantey Wednesday, December 19, 2012 8:35:16 AM
Re: None


"Big pharma" development partnership(s) or buyout in 2013.

$1.00 or more.

Major drug companies have billions of dollars to spend on acquisitions or partnerships.

AMBS is the most undervalued bio-tech in the market.

.20-.25 by 12/31/2012.

The co-founder of Amgen is 100% correct when he stated that the company's MANF technology would be worth billions and be a blockbuster drug.


http://investorshub.advfn.com/boards/read_msg.aspx?message_id=82611213





"I have been driven many times upon my knees by the overwhelming conviction that I had nowhere else to go."
Abraham Lincoln

"Jesus.....wise men still seek him"

[familyof5]

Solantey your AMBS $1.00 PPS prediction is low considering...


CEO BLOG (1/14/2013) Onwards and Upwards: Building Value From a Solid Foundation

SOURCE: http://www.thechairmansblog.com/gerald-commissiong/2013-01/onwards-and-upwards-building-value-from-a-solid-foundation.html



"Big pharma" development partnership(s) or buyout in 2013. $1.00 or more.AMBS is the most undervalued bio-tech in the market." Solantey





Solantey Wednesday, December 19, 2012 8:35:16 AM
Re: None


"Big pharma" development partnership(s) or buyout in 2013.

$1.00 or more.

Major drug companies have billions of dollars to spend on acquisitions or partnerships.

AMBS is the most undervalued bio-tech in the market.

.20-.25 by 12/31/2012.

The co-founder of Amgen is 100% correct when he stated that the company's MANF technology would be worth billions and be a blockbuster drug.


http://investorshub.advfn.com/boards/read_msg.aspx?message_id=82611213





"I have been driven many times upon my knees by the overwhelming conviction that I had nowhere else to go."
Abraham Lincoln

"Jesus.....wise men still seek him"

[familyof5]

"AMBS most undervalued bio-tech in the market" Solantey



Solantey I agree but your AMBS $1.00 PPS prediction is low considering...
CEO BLOG (1/14/2013) Onwards and Upwards: Building Value From a Solid Foundation
SOURCE: http://www.thechairmansblog.com/gerald-commissiong/2013-01/onwards-and-upwards-building-value-from-a-solid-foundation.html



"Big pharma" development partnership(s) or buyout in 2013. $1.00 or more.AMBS is the most undervalued bio-tech in the market." Solantey


Solantey Wednesday, December 19, 2012 8:35:16 AM
Re: None


"Big pharma" development partnership(s) or buyout in 2013.

$1.00 or more.

Major drug companies have billions of dollars to spend on acquisitions or partnerships.

AMBS is the most undervalued bio-tech in the market.

.20-.25 by 12/31/2012.

The co-founder of Amgen is 100% correct when he stated that the company's MANF technology would be worth billions and be a blockbuster drug.


http://investorshub.advfn.com/boards/read_msg.aspx?message_id=82611213





"I have been driven many times upon my knees by the overwhelming conviction that I had nowhere else to go."
Abraham Lincoln

"Jesus.....wise men still seek him"

[familyof5]

Solantey your AMBS $1.00 PPS prediction is low considering...


CEO BLOG (1/14/2013) Onwards and Upwards: Building Value From a Solid Foundation
SOURCE: http://www.thechairmansblog.com/gerald-commissiong/2013-01/onwards-and-upwards-building-value-from-a-solid-foundation.html



"Big pharma" development partnership(s) or buyout in 2013. $1.00 or more.AMBS is the most undervalued bio-tech in the market." Solantey




Solantey Wednesday, December 19, 2012 8:35:16 AM
Re: None


"Big pharma" development partnership(s) or buyout in 2013.

$1.00 or more.

Major drug companies have billions of dollars to spend on acquisitions or partnerships.

AMBS is the most undervalued bio-tech in the market.

.20-.25 by 12/31/2012.

The co-founder of Amgen is 100% correct when he stated that the company's MANF technology would be worth billions and be a blockbuster drug.


http://investorshub.advfn.com/boards/read_msg.aspx?message_id=82611213





"I have been driven many times upon my knees by the overwhelming conviction that I had nowhere else to go."
Abraham Lincoln

"Jesus.....wise men still seek him"

[hemo_nurse]

NICE CALL SOLANTEY!!!! YEAH!!